Hospital
Exeter Hospital INC
Exeter Hospital INC was paid $12.54M by Medicaid between Jan 2018 and Nov 2024, across 179 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoEXETER HOSPITAL INC
EXETER, NH 03833
EXETER, NH 03833
33aNPI1437158433assigned 07/20/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.54M
24GClaims332,098
24DCodes billed179
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in New Hampshire
Rank by total paid#4 of 9
Median peer was paid$10.80M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,606 | $1.57M | |
| 2019 | 68,075 | $2.87M | |
| 2020 | 57,201 | $2.70M | |
| 2021 | 75,595 | $3.01M | |
| 2022 | 51,096 | $1.89M | |
| 2023 | 13,210 | $262K | |
| 2024incomplete | 10,315 | $243K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 12,467 | 9,711 | $2.01M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.8% | 2,091 | 1,668 | $1.23M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.5% | 7,027 | 5,817 | $812K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 3,079 | 2,392 | $756K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6.0% | 15,382 | 4,478 | $756K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.0% | 18,750 | 5,262 | $496K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.2% | 4,669 | 3,440 | $408K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.0% | 16,407 | 4,697 | $378K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 1,945 | 1,420 | $343K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.7% | 6,789 | 2,110 | $334K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.1% | 1,252 | 616 | $262K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 3,056 | 2,569 | $226K |
167 more codes
| G0378 | Hospital observation service, per hour | 1.8% | 1,215 | $224K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 4,578 | $185K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 3,678 | $168K |
| J2704 | Injection, propofol, 10 mg | 1.3% | 4,971 | $165K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 1,914 | $158K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 1,295 | $156K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.2% | 455 | $150K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 6,635 | $146K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 5,216 | $143K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.1% | 409 | $133K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 375 | $121K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,206 | $114K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,307 | $110K |
| 80053 | Comprehensive metabolic panel | <1% | 18,903 | $101K |
| 97113 | <1% | 2,801 | $99K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 489 | $98K |
| 97161 | <1% | 2,390 | $98K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,123 | $91K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,547 | $86K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,196 | $81K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 407 | $76K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,122 | $69K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,498 | $65K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 188 | $64K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 68 | $60K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 119 | $59K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 279 | $58K |
| 93971 | <1% | 483 | $58K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 762 | $57K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 418 | $54K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 132 | $53K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 400 | $50K |
| 76830 | Ultrasound, transvaginal | <1% | 397 | $47K |
| 97597 | <1% | 883 | $42K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 176 | $41K |
| 76642 | <1% | 464 | $38K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 382 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 616 | $37K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,525 | $36K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 94 | $36K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,347 | $34K |
| 96367 | <1% | 216 | $33K | |
| 97165 | <1% | 719 | $32K | |
| 97162 | <1% | 870 | $32K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 921 | $31K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 947 | $28K |
| 76770 | <1% | 296 | $27K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,778 | $25K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,294 | $22K |
| 96376 | <1% | 646 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,428 | $20K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 807 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 487 | $20K |
| 77002 | <1% | 272 | $18K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,674 | $18K |
| 84484 | <1% | 4,380 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 502 | $18K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,551 | $18K |
| 83735 | <1% | 3,978 | $15K | |
| 97116 | <1% | 862 | $15K | |
| 83690 | <1% | 3,769 | $14K | |
| 74018 | <1% | 303 | $14K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,059 | $13K |
| 59025 | Fetal non-stress test | <1% | 128 | $13K |
| 93976 | <1% | 141 | $13K | |
| 93017 | <1% | 99 | $12K | |
| 84703 | <1% | 2,449 | $12K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,283 | $11K |
| 77066 | Tomosynthesis, mammo | <1% | 114 | $11K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,429 | $10K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,195 | $10K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,066 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,921 | $9K |
| 97035 | <1% | 478 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,199 | $7K |
| 73030 | <1% | 169 | $7K | |
| 73630 | <1% | 161 | $7K | |
| 76536 | <1% | 81 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,871 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,247 | $7K |
| 81001 | <1% | 4,242 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 155 | $7K |
| 81025 | <1% | 1,602 | $7K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 684 | $7K |
| 71250 | <1% | 33 | $6K | |
| 82948 | <1% | 3,535 | $6K | |
| 82077 | <1% | 664 | $6K | |
| 73610 | <1% | 138 | $6K | |
| 80061 | Lipid panel | <1% | 633 | $6K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,210 | $5K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 29 | $5K |
| 87077 | <1% | 1,102 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 621 | $5K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 146 | $4K |
| 82728 | <1% | 475 | $4K | |
| 76801 | <1% | 43 | $4K | |
| 85379 | <1% | 666 | $4K | |
| 87040 | <1% | 602 | $4K | |
| 73110 | <1% | 79 | $3K | |
| 73130 | <1% | 63 | $3K | |
| 87186 | <1% | 746 | $3K | |
| 88304 | <1% | 174 | $3K | |
| 86140 | <1% | 856 | $3K | |
| 85610 | <1% | 1,507 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $3K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 89 | $3K |
| 82607 | <1% | 303 | $2K | |
| 76942 | <1% | 17 | $2K | |
| 83605 | <1% | 407 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 255 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,216 | $2K |
| 72100 | <1% | 34 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 369 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 17 | $2K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 519 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 271 | $2K |
| 83550 | <1% | 288 | $2K | |
| 20610 | <1% | 13 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 137 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 15 | $2K |
| 83540 | <1% | 356 | $2K | |
| 81003 | <1% | 1,670 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $2K |
| 80143 | <1% | 139 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 764 | $1K |
| A9270 | Non-covered item or service | <1% | 14,313 | $1K |
| 82746 | <1% | 114 | $1K | |
| 80179 | <1% | 115 | $1K | |
| 94729 | <1% | 34 | $1K | |
| 74019 | <1% | 13 | $1K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 14 | $1K |
| 77065 | Tomosynthesis, mammo | <1% | 21 | $1K |
| 85651 | <1% | 483 | $1K | |
| 85730 | <1% | 351 | $1K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 148 | $1K |
| 94010 | <1% | 19 | $1K | |
| 87081 | <1% | 234 | $994.36 | |
| 84100 | <1% | 384 | $978.26 | |
| 87070 | <1% | 229 | $936.08 | |
| 73564 | <1% | 17 | $916.83 | |
| 83880 | <1% | 57 | $850.08 | |
| 94726 | <1% | 19 | $715.50 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 924 | $711.74 |
| 87420 | <1% | 60 | $601.56 | |
| 84145 | <1% | 38 | $473.05 | |
| 36591 | <1% | 20 | $463.97 | |
| 73502 | <1% | 16 | $457.87 | |
| 82784 | <1% | 28 | $430.35 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 111 | $424.05 |
| 85027 | <1% | 61 | $286.62 | |
| 84439 | <1% | 46 | $276.48 | |
| 86618 | <1% | 35 | $260.90 | |
| 86850 | <1% | 29 | $253.65 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $244.41 |
| 80050 | General health panel | <1% | 29 | $205.90 |
| 86901 | <1% | 68 | $163.64 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 17 | $152.09 |
| 83615 | <1% | 35 | $110.57 | |
| 86900 | <1% | 48 | $99.81 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 204 | $87.85 |
| 84550 | <1% | 23 | $84.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 58 | $8.03 |
| 99153 | Mod sedat endo service >5yrs | <1% | 16 | $3.59 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 16 | $2.41 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 240 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 295 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASASSA, ALLISON (CFO)